A Leaner Merck Says, 'So Long, Seattle'

GenomeWeb
360Dx
Precision Oncology News

GenomeWeb

A Leaner Merck Says, 'So Long, Seattle'

Oct 24, 2008

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

Guardant Health Q4 Revenues Up 25 Percent
Adaptive Biotechnologies Q4 Revenues Rise 25 Percent
CareDx Q4 Revenues Up 64 Percent
Walgreens to Sell Labcorp COVID-19 PCR Home Collection Kits Over-the-Counter
Cytox Gets CE Mark for Alzheimer's Disease Genetic Risk Test
Proteogenomic Study Expands Catalog of Cell Cycle Players

The Scan

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

Support for Another

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

New Prototype Test

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.

Menu

A Leaner Merck Says, 'So Long, Seattle'

To read the full story....

Breaking News

Guardant Health Q4 Revenues Up 25 Percent

Adaptive Biotechnologies Q4 Revenues Rise 25 Percent

CareDx Q4 Revenues Up 64 Percent

Walgreens to Sell Labcorp COVID-19 PCR Home Collection Kits Over-the-Counter

Cytox Gets CE Mark for Alzheimer's Disease Genetic Risk Test

Proteogenomic Study Expands Catalog of Cell Cycle Players

The Scan

COVAX's First Shipment

Support for Another

New Prototype Test

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

Sponsorships